US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

All estriol Products

Reason Lack of Processing Controls

Reliable Rexall-A Compounding Pharmacy D-1070-2016
Class II · Moderate risk Terminated

All testosterone Products

Reason Lack of Processing Controls

Reliable Rexall-A Compounding Pharmacy D-1069-2016
Class II · Moderate risk Terminated

All 4-aminopyridine Products

Reason Lack of Processing Controls

Reliable Rexall-A Compounding Pharmacy D-1067-2016
Class II · Moderate risk Terminated

PerioRx

Reason Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) for an unknown impurity of Chlorhexidine gluconate.

Akorn, Inc. D-0876-2016
Class II · Moderate risk Terminated

Chlorhexidine gluconate

Reason Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) for an unknown impurity of Chlorhexidine gluconate.

Akorn, Inc. NDC 5083-0720-16 D-0875-2016
Class II · Moderate risk Terminated

Oris

Reason Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) for an unknown impurity of Chlorhexidine gluconate.

Akorn, Inc. D-0874-2016
Class II · Moderate risk Terminated

Renovo Patch

Reason Marketed Without An Approved NDA/ANDA: product is an unapproved drug and additionally 3 lots were found to be subpotent.

TMIG Inc D-0855-2016
Class II · Moderate risk Terminated

Dextroamphetamine Sulfate Tablets USP

Reason Failed Impurities/Degradation Specifications

Impax Laboratories, Inc. NDC 64720-215-10 D-0826-2016
Class II · Moderate risk Terminated

Dextroamphetamine Sulfate Tablets USP

Reason Failed Impurities/Degradation Specifications

Impax Laboratories, Inc. NDC 64720-0216-10 D-0825-2016
Class II · Moderate risk Terminated

Formula 2

Reason Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.

Meditech Laboratories, Inc D-0808-2016
Class II · Moderate risk Terminated

Formula 0

Reason Lack of Assurance of Sterility: incomplete or missing data regarding production.

Meditech Laboratories, Inc D-0807-2016
Class II · Moderate risk Terminated

Formula 3

Reason Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.

Meditech Laboratories, Inc D-0806-2016
Class II · Moderate risk Terminated

Formula 1

Reason Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.

Meditech Laboratories, Inc D-0805-2016
Class II · Moderate risk Terminated

Formula 9

Reason Lack of Assurance of Sterility: incomplete or missing data regarding production.

Meditech Laboratories, Inc D-0804-2016
Class II · Moderate risk Terminated

Formula 4

Reason Lack of Assurance of Sterility: incomplete or missing data regarding production.

Meditech Laboratories, Inc D-0803-2016
Class II · Moderate risk Terminated

Formula 2

Reason Superpotent Drug: one ingredient was found to be above assay specification.

Meditech Laboratories, Inc D-0802-2016
Class II · Moderate risk Terminated

Potassium Chloride Injection 20 mEq

Reason Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

Hospira Inc. NDC 0409-7077-14 D-0832-2016
Class II · Moderate risk Terminated

Mannitol I.V.

Reason Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

Hospira Inc. D-0831-2016
Class II · Moderate risk Terminated

Aminosyn-PF

Reason Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

Hospira Inc. D-0830-2016
Class II · Moderate risk Terminated

Dextrose Injection

Reason Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

Hospira Inc. NDC 0409-7935-19 D-0829-2016
Class II · Moderate risk Terminated

Dextrose Injection

Reason Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

Hospira Inc. NDC 0409-7936-19 D-0828-2016
Class II · Moderate risk Terminated

Dextrose Injection

Reason Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

Hospira Inc. NDC 0409-7918-19 D-0827-2016
Class II · Moderate risk Terminated

Zoledronic Acid Injection

Reason Lack of Assurance of Sterility; defective seals where the metal silver ring was not attached tightly to the vial

Dr. Reddy's Laboratories, Inc. NDC 55111-688-52 D-0784-2016
Class II · Moderate risk Terminated

Fluconazole Injection

Reason Cross contamination with other products: metronidazole

Sagent Pharmaceuticals Inc NDC 25021-0113-82 D-0780-2016
Class II · Moderate risk Terminated

Dextroamphetamine Saccharate

Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.

Actavis Elizabeth LLC D-0816-2016